Latest Regulatory Approval News

AdAlta’s partner SHcell has gained regulatory approval to provide the BZDS1901 CAR-T therapy to advanced mesothelioma patients in China’s Hainan Boao Lecheng special access zone, marking a key milestone in real-world data collection and treatment availability.

Kantra Copper (ASX:KAN) showcased a robust growth strategy at the Copper to the World Conference, spotlighting its Kanmantoo mine extension, Emily Star development, and advancing exploration projects. The company maintains strong production guidance and financial health amid a tightening copper market.

Energy One Limited (ASX:EOL) reported a robust FY2026 with a 17% increase in recurring revenue and a 51% jump in net profit before tax, while preparing for a transformative acquisition of Gas Management Services Limited to deepen its European market presence.

Ore Resources Ltd has secured six additional tenements at its Miriam Gold Project, creating a contiguous landholding that expands exploration potential along the Miriam Shear Zone. The acquisition positions the company for targeted drilling campaigns in 2026 and beyond.

Telix Pharmaceuticals has completed enrollment in its pivotal Phase 3 BiPASS trial for prostate cancer imaging and aligned with the FDA on a pathway that could expand U.S. patient access and reimbursement for its 68Ga-PSMA-PET agents.

Alcoa Corporation has filed to register shares of its common stock to be issued in connection with its $4.1 billion acquisition of South32 Limited’s upstream aluminum assets, spanning Australia, Brazil and South Africa. The deal includes cash, stock consideration, and contingent payments linked to commodity prices, pending customary approvals and shareholder support.

X2M Connect has secured a non-binding five-year partnership to develop AI-enabled GPU data centre precincts in regional Queensland, boosting its project pipeline to over 200MW and integrating its AI management platform across energy and environmental systems.

Peppermint Innovation Limited posted a $2.4 million net loss for FY26 as it shifted from platform development to commercial execution in the Philippines, achieving key regulatory milestones and securing strategic investment.

Audeara Limited delivered record FY26 revenue of $4.45 million, driven by a 45% surge in Australian wholesale sales and progress in AI audio licensing with OPTEK Microelectronics. The company narrowed its loss and advanced Auracast deployments across retirement villages and education sectors.

Wide Open Agriculture cut its loss to $3.64 million in FY2026 as it pivots from owning manufacturing to a capital-light contract model, while securing global commercial traction for its lupin-based ingredients.

Atomo Diagnostics lifted revenue 41% to AUD 5.33 million for FY26, cutting its loss by 29% to AUD 3.51 million, driven by HIV self-testing growth and a key US partnership. Leadership changes signal a strategic pivot as the company eyes global expansion.

CurveBeam AI’s FY2026 results show a 28% revenue decline and a 12% increase in net loss, while advancing its China commercialisation and robotic surgery integration strategies. The company also announced a $6-7 million capital raise post-year-end.